News for Solara Active Pharma Sciences Limited (SOLARA.NS)

May 15, 2025 / 10:00AM GMTOperator Ladies and gentlemen, good day, and welcome to the Solara Active Pharma Sciences Limited Q4 FY25 Earnings Conference Call. (O

Jan 24, 2025 / 10:00AM GMTOperator Ladies and gentlemen, good day, and welcome to the Solara Active Pharma Sciences Limited Q3 FY25 earnings conference call. (O

Oct 21, 2024 / 10:00AM GMTOperator Ladies and gentlemen, good day, and welcome to Solara Active Pharma Sciences Limited Q2 and H1 FY25 earnings conference call.

Solara Active Pharma Sciences Ltd (Solara) has announced the closure of its rights issue for raising funds aggregating to ₹449.95 crore.

Aug 03, 2020 / 10:00AM GMTAbhishek Singhal - Solara Active Pharma Sciences Limited - IR Thank you for joining us today for Solara Active Pharma Sciences' earnin

May 07, 2020 / 09:00AM GMTOperator -- Q4 FY 20 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I would now

Feb 14, 2024 / 09:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the Solara active Pharma Sciences Limited Q3 FY24 earnings conference call. (O

Smallcap World Fund offloaded shares in Dreamfolks Services, and Shriram Finance, but bought in Aavas Financiers via block deals.

Prophecy Market Insights latest research report on the Active Pharmaceutical Ingredient market provides a comprehensive analysis of the current market...

The pharma company also told exchanges that Aditya Puri has resigned as the chairman and non-executive director

US FDA inspected the unit, which is a multi-product facility, and found it to be in an “acceptable state of compliance”, the company said

After an extremely negative week, the key benchmark indices were seen fluctuating between gains and losses in Monday's trading session. The BSE Sensex gyrated between zones, and was up 100-odd points at 51,470, the NSE Nifty 50 reclaimed 15,300-level.

India is currently the worlds largest supplier of generic medications, accounting for 20% of global supply by volume and roughly 60% of global demand for vaccines. Looking at present market conditions a do global affairs, the 2022 equity market is challenging. However, investing based on sector might be a good decision.

Indian benchmark indices extended gains on Tuesday, led by strong gains in index heavyweights ITC and Reliance. The broader markets were also up in sync with the benchmark indices.

Tracking weak global sentiment, Indian benchmark indices started the week with deep cuts. The BSE Sensex was down 300 points to 56,740, while the NSE Nifty 50 continued to test the 17,000-mark.

Based on the open interest future percentage, here are 133 stocks including NTPC, Oracle Financial Services Software, Escorts, Indus Towers, and United Breweries, in which short-covering was seen.

As per the pivot charts, the key support levels for the Nifty are placed at 17,300.27, followed by 17,225.73. If the index moves up, the key resistance levels to watch out for are 17,452.07 and 17,529.33.

BSE Sensex and Nifty 50 were trading over half a per cent a higher on Thursday, on the back of buying in index heavyweights